相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome
Alejandra Martinez-Trillos et al.
BLOOD (2014)
Bone marrow neoplastic niche in leukemia
Shirin Azizidoost et al.
HEMATOLOGY (2014)
Prognostic and Predictive Factors in Patients With Chronic Lymphocytic Leukemia: Relevant in the Era of Novel Treatment Approaches?
Daniel Mertens et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia
Lu Qian Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Multidimensional Single-Cell Analysis of BCR Signaling Reveals Proximal Activation Defect As a Hallmark of Chronic Lymphocytic Leukemia B Cells
M. Lia Palomba et al.
PLOS ONE (2014)
The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies
Jan A. Burger et al.
SEMINARS IN CANCER BIOLOGY (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status
Lene Rask et al.
CELLULAR ONCOLOGY (2014)
Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents - implications for cancer treatment and chemoprevention
Eugenia Yiannakopoulou
CELLULAR ONCOLOGY (2014)
Identification of prognostic relevant chromosomal abnormalities in chronic lymphocytic leukemia using microarray-based genomic profiling
Marian J. P. L. Stevens-Kroef et al.
MOLECULAR CYTOGENETICS (2014)
Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment
Michael Hallek
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients
Larry Mansouri et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2013)
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Dan A. Landau et al.
CELL (2013)
Recent advances in microRNA-mediated gene regulation in chronic lymphocytic leukemia
Swati Srivastava et al.
CLINICAL BIOCHEMISTRY (2013)
Cap-Translation Inhibitor, 4EGI-1, Restores Sensitivity to ABT-737 Apoptosis through Cap-Dependent and -Independent Mechanisms in Chronic Lymphocytic Leukemia
Shaun Willimott et al.
CLINICAL CANCER RESEARCH (2013)
Uncovering the DNA methylome in chronic lymphocytic leukemia
Nicola Cahill et al.
EPIGENETICS (2013)
Regulation of the MIR155 host gene in physiological and pathological processes
Terry S. Elton et al.
GENE (2013)
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
Robin Foa et al.
HAEMATOLOGICA (2013)
Molecular bases of chronic lymphocytic leukemia in light of new treatments
Davide Rossi et al.
IMMUNOLOGY LETTERS (2013)
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells
Uri Rozovski et al.
MOLECULAR CANCER (2013)
LCK Is an Important Mediator of B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia Cells
Fatima Talab et al.
MOLECULAR CANCER RESEARCH (2013)
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia
L. Mansouri et al.
LEUKEMIA (2013)
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients
S. Weissmann et al.
LEUKEMIA (2013)
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
Richard Rosenquist et al.
LEUKEMIA & LYMPHOMA (2013)
B cell receptor signaling in chronic lymphocytic leukemia
Jan A. Burger et al.
TRENDS IN IMMUNOLOGY (2013)
Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia
Edurne San Jose-Eneriz et al.
EPIGENOMICS (2013)
Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease
Ana E. Rodriguez-Vicente et al.
CANCER GENETICS (2013)
MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma
Yuanyuan Wang et al.
CELLULAR ONCOLOGY (2013)
Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics
Dan A. Landau et al.
GENOME MEDICINE (2013)
Aberrant Activation of the Hedgehog Signaling Pathway in Malignant Hematological Neoplasms
Chi Young Ok et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
Deepa Sampath et al.
BLOOD (2012)
NOTCH1 mutations in CLL associated with trisomy 12
Veronica Balatti et al.
BLOOD (2012)
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2012)
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia
Adrian Wiestner
BLOOD (2012)
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2012)
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
Martin F. M. de Rooij et al.
BLOOD (2012)
Extensive Promoter DNA Hypermethylation and Hypomethylation Is Associated with Aberrant MicroRNA Expression in Chronic Lymphocytic Leukemia
Constance Baer et al.
CANCER RESEARCH (2012)
The Akt-associated microRNAs
Min Xu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia
Lirong Pei et al.
EPIGENETICS (2012)
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
Lidia Rita Corsini et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia
Peter Ouillette et al.
GENES CHROMOSOMES & CANCER (2012)
ATM and chronic lymphocytic leukemia: mutations, and not only deletions, matter
Davide Rossi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Molecular pathogenesis of chronic lymphocytic leukemia
Gianluca Gaidano et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Quantitative DNA Methylation Analysis Identifies a Single CpG Dinucleotide Important for ZAP-70 Expression and Predictive of Prognosis in Chronic Lymphocytic Leukemia
Rainer Claus et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial
Andrew R. Pettitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia
Keshu Zhou et al.
LEUKEMIA & LYMPHOMA (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
Marta Kulis et al.
NATURE GENETICS (2012)
DNA damage checkpoints in stem cells, ageing and cancer
Tobias Sperka et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy
A. H. Nwabo Kamdje et al.
BLOOD CANCER JOURNAL (2012)
Aberrant microRNA expression and its implications in the pathogenesis of leukemias
Sadegh Babashah et al.
CELLULAR ONCOLOGY (2012)
Inhibiting B-Cell Receptor Signaling Pathways in Chronic Lymphocytic Leukemia
Jan A. Burger
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2012)
Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL
Dimitar G. Efremov et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2012)
Integration of B cell responses through Toll-like receptors and antigen receptors
David J. Rawlings et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
Julia Hoellenriegel et al.
BLOOD (2011)
B-cell receptor signaling in chronic lymphocytic leukemia
Freda K. Stevenson et al.
BLOOD (2011)
Insulin Receptor Activation in Deletion 11q Chronic Lymphocytic Leukemia
Jennifer R. Brown
CLINICAL CANCER RESEARCH (2011)
Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells
Alba Perez-Perarnau et al.
EPIGENETICS (2011)
Expression Analysis of Genes Located in the Minimally Deleted Regions of 13q14 and 11q22-23 in Chronic Lymphocytic Leukemia-Unexpected Expression Pattern of the RHO GTPase Activator ARHGAP20
Tobias Herold et al.
GENES CHROMOSOMES & CANCER (2011)
13q14 Deletion Size and Number of Deleted Cells Both Influence Prognosis in Chronic Lymphocytic Leukemia
Michele Dal Bo et al.
GENES CHROMOSOMES & CANCER (2011)
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients
Eleni Arvaniti et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Applications of next generation sequencing in molecular ecology of non-model organisms
R. Ekblom et al.
HEREDITY (2011)
Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus
Lukas P. Frenzel et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
MicroRNA-146a and hemopoietic disorders
Zhong Hua et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think
Camille Lobry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
Giulia Fabbri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies
R. G. Wickremasinghe et al.
LEUKEMIA (2011)
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers
Jason A. Dubovsky et al.
LEUKEMIA RESEARCH (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies
Kwan Yeung Wong et al.
PLOS ONE (2011)
Functions of Notch Signaling in the Immune System: Consensus and Controversies
Julie S. Yuan et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells
Xueqing Liang et al.
BLOOD (2010)
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27
Michela Frenquelli et al.
BLOOD (2010)
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
Sarah E. M. Herman et al.
BLOOD (2010)
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
Simona Rossi et al.
BLOOD (2010)
A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia
Daniel L. Van Dyke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL
Paolo Sportoletti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
MicroRNA and drug resistance
J. Ma et al.
CANCER GENE THERAPY (2010)
MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application
S. Patrick Nana-Sinkam et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia
Mats Merup et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
Manuela Ferracin et al.
MOLECULAR CANCER (2010)
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia
Andrea G. S. Buggins et al.
LEUKEMIA RESEARCH (2010)
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
Su-Chang Lin et al.
NATURE (2010)
Histone deacetylases and epigenetic therapies of hematological malignancies
Ciro Mercurio et al.
PHARMACOLOGICAL RESEARCH (2010)
Antigens in chronic lymphocytic leukemia-Implications for cell origin and leukemogenesis
Anders Rosen et al.
SEMINARS IN CANCER BIOLOGY (2010)
New insights into the pathogenesis of chronic lymphocytic leukemia
Ulf Klein et al.
SEMINARS IN CANCER BIOLOGY (2010)
Regulation and Function of NF-kappa B Transcription Factors in the Immune System
Sivakumar Vallabhapurapu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation
Jan A. Burger et al.
BLOOD (2009)
Karyotype-specific microRNA signature in chronic lymphocytic leukemia
Rosa Visone et al.
BLOOD (2009)
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification
Basile Stamatopoulos et al.
BLOOD (2009)
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial
Thorsten Zenz et al.
BLOOD (2009)
De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience
Constantine S. Tam et al.
BLOOD (2009)
Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification
Marian Stevens-Kroef et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Epigenetic alterations in a murine model for chronic lymphocytic leukemia
Shih-Shih Chen et al.
CELL CYCLE (2009)
The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
Davide Rossi et al.
CLINICAL CANCER RESEARCH (2009)
A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia
Jose Angel Hernandez et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes
Marek Mraz et al.
LEUKEMIA & LYMPHOMA (2009)
Molecular basis of pathogenesis, prognosis and therapy in chronic lymphocytic leukaemia
Jiezhong Chen et al.
CANCER BIOLOGY & THERAPY (2008)
Applications of next-generation sequencing technologies in functional genomics
Olena Morozova et al.
GENOMICS (2008)
Hedgehog-Induced Survival of B-Cell Chronic Lymphocytic Leukemia Cells in a Stromal Cell Microenvironment: A Potential New Therapeutic Target
Ganapati V. Hegde et al.
MOLECULAR CANCER RESEARCH (2008)
Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
Martin F. Lavin
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia
Peter Hillmen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion
Belinda Austen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Comprehensive genetic characterization of CLL:: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping
C. Haferlach et al.
LEUKEMIA (2007)
B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle
Fiona Bennett et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
mir-29 regulates Mcl-1 protein expression and apoptosis
J. L. Mott et al.
ONCOGENE (2007)
Hypermethylation of the p15INK48 gene promoter in B-chronic lymphocytic leukemia
Sotirios G. Papageorgiou et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival
Stephan Stilgenbauer et al.
HAEMATOLOGICA (2007)
Methods and strategies for analyzing copy number variation using DNA microarrays
Nigel P. Carter
NATURE GENETICS (2007)
CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia
Par Josefsson et al.
BLOOD (2007)
Genome-wide copy number profiling on high-density bacterial artificial chromosomes, single-nucleotide polymorphisms, and oligonucleotide microarrays: A platform comparison based on statistical power analysis
Jayne Y. Hehir-Kwa et al.
DNA RESEARCH (2007)
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays
Dietmar Pfeifer et al.
BLOOD (2007)
Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181
Yuri Pekarsky et al.
CANCER RESEARCH (2006)
MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by α4β1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration
Javier Redondo-Munoz et al.
BLOOD (2006)
Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia
Kensuke Kojima et al.
BLOOD (2006)
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells
Llorenc Coll-Mulet et al.
BLOOD (2006)
DHMEQ, a new NF-κB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells
R Horie et al.
LEUKEMIA (2006)
Recent insights into the role of Notch signaling in tumorigenesis
KG Leong et al.
BLOOD (2006)
Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia
P Tsirigotis et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state
M Herling et al.
LEUKEMIA (2006)
Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia
RE Shackelford et al.
MEDICAL HYPOTHESES (2006)
Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL
B Austen et al.
BLOOD (2005)
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Identification of disease genes by whole genome CGH arrays
LELM Vissers et al.
HUMAN MOLECULAR GENETICS (2005)
Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer
SE Artandi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Mechanisms of disease: Chronic lymphocytic leukemia
N Chiorazzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Chronic lymphocytic leukemia with 6q-shows distinct hematological features and intermediate prognosis
A Cuneo et al.
LEUKEMIA (2004)
Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL)
KN Harikrishnan et al.
CANCER BIOLOGY & THERAPY (2004)
Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination
S López-Giral et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity
G Müller et al.
IMMUNOLOGICAL REVIEWS (2003)
The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells
E Bourke et al.
BLOOD (2003)
CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease
J Barretina et al.
ANNALS OF HEMATOLOGY (2003)
Genetics of chronic lymphocytic leukemia:: genomic aberrations and VH gene mutation status in pathogenesis and clinical course
S Stilgenbauer et al.
LEUKEMIA (2002)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control
AL Shaffer et al.
IMMUNITY (2000)
分享论文
